Creo Medical Group plc announced continued progress on the phased market release of its latest device, Speedboat UltraSlim, which has now been successfully used in the Asia Pacific region ("APAC") for the first time. Speedboat UltraSlim was used at the Prince of Wales Hospital Hong Kong in late January, where Dr. Hon Chi Yip and Dr. Simon Chu performed several procedures to treat precancerous lesions in the colon and stomach. Since December 2023 Speedboat UltraSlim has been successfully used in multiple clinical applications and in multiple jurisdictions: the UK, USA, LATAM and now APAC, as well as expanding indications treating different disease states and conditions.

The device has been used to treat precancerous lesions In the colon, oesophagus and stomach as well as during procedures to surgically correct gastric and oesophageal abnormalities to help patients with swallowing and acid reflux disorders. The performance of the advanced energy has increased the efficiency of the procedure.